Same Indication

Metformin vs Yttrium Y 90 Ibritumomab Tiuxetan

Metformin vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between Metformin and Yttrium Y 90 Ibritumomab Tiuxetan.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Pharmacokinetics

Half-life: Metformin — 4-9 hours.

Chemical Properties

Molecular Formula: Metformin — C4H11N5.

Molecular Weight: Metformin — 129.1640 g/mol.

Type: Metformin — Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.